Antibody responses to the merozoite surface protein-1 complex in cerebral malaria patients in India

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Lucchi, Naomi W ^a   Tongren, Jon Eric ^a   Jain, Vidhan ^b   Nagpal, Avinash C ^c   Kauth, Christian W ^d   Woehlbier, Ute ^d   Bujard, Hermann ^d   Dash, Aditya P ^e   Singh, Neeru ^b   Stiles, Jonathan K ^f   Udhayakumar, Venkatachalam ^a,g  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^c NSCB MEDICAL COLLEGE   (India)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^f MOREHOUSE SCHOOL OF MEDICINE   (United States)

^g ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MEROZOITE SURFACE PROTEIN 1; RECOMBINANT ANTIGEN; DIAGNOSTIC AGENT; PARASITE ANTIGEN; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN;

ADULT; ANTIBODY RESPONSE; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INDIA; MALE; PATHOGENESIS; PREVALENCE; ANIMAL; BLOOD; COMPARATIVE STUDY; IMMUNOLOGY; MALARIA; MALARIA FALCIPARUM; PARASITOLOGY; PLASMODIUM FALCIPARUM;

ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INDIA; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; MALE; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM FALCIPARUM; RECOMBINANT PROTEINS;

EID: 48449083725     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-121     Document Type: Article

References (64)

1. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. CR Newton S Krishna, Pharmacol Ther 1998 79 1 53 10.1016/S0163-7258(98)00008-4 9719344
2. Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. JA Carter V Mung'ala-Odera BG Neville G Murira N Mturi C Musumba CR Newton, J Neurol Neurosurg Psychiatry 2005 76 476 481 15774431 10.1136/jnnp.2004.043893
3. Increased prevalence of epilepsy associated with severe falciparum malaria in children. JA Carter BG Neville S White AJ Ross G Otieno N Mturi C Musumba CR Newton, Epilepsia 2004 45 978 981 10.1111/j.0013-9580.2004.65103.x 15270766
4. Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. R Idro M Ndiritu B Ogutu S Mithwani K Maitland J Berkley J Crawley G Fegan E Bauni N Peshu K Marsh B Neville C Newton, Jama 2007 297 2232 2240 10.1001/jama.297.20.2232 17519413
5. The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in sub-saharan Africa. V Mung'Ala-Odera RW Snow CR Newton, Am J Trop Med Hyg 2004 71 64 70 15331820
6. Cerebral malaria in rural India. MB Kamble PP Raut ZF Hussain, Indian J Pediatr 2002 69 659 661 10.1007/BF02722697 12356215
7. Indicators of life-threatening malaria in African children. K Marsh D Forster C Waruiru I Mwangi M Winstanley V Marsh C Newton P Winstanley P Warn N Peshu G Pasvol R Snow, N Engl J Med 1995 332 1399 1404 10.1056/ NEJM199505253322102 7723795
8. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. ME Molyneux TE Taylor JJ Wirima A Borgstein, Q J Med 1989 71 441 459 2690177
9. Epidemiology of malaria in an area of low transmission in central India. N Singh SK Chand AK Mishra PK Bharti MP Singh TP Ahluwalia AP Dash, Am J Trop Med Hyg 2006 75 812 816 17123970
10. Genetic analysis of circulating and sequestered populations of Plasmodium falciparum in fatal pediatric malaria. J Montgomery DA Milner Jr MT Tse A Njobvu K Kayira CP Dzamalala TE Taylor SJ Rogerson AG Craig ME Molyneux, J Infect Dis 2006 194 115 122 10.1086/504689 16741890
11. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. TE Taylor WJ Fu RA Carr RO Whitten JS Mueller NG Fosiko S Lewallen NG Liomba ME Molyneux, Nat Med 2004 10 143 145 10.1038/nm986 14745442
12. Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. E Pongponratn M Riganti B Punpoowong M Aikawa, Am J Trop Med Hyg 1991 44 168 175 2012260
13. Role of TNF in cerebral malaria. IA Clark KA Rockett WB Cowden, Lancet 1991 337 302 303 10.1016/0140-6736(91)90915-C 1671139
14. High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria. H Armah AK Dodoo EK Wiredu JK Stiles AA Adjei RK Gyasi Y Tettey, Ann Trop Med Parasitol 2005 99 629 647 10.1179/136485905X51508 16212798
15. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. HB Armah NO Wilson BY Sarfo MD Powell VC Bond W Anderson AA Adjei RK Gyasi Y Tettey EK Wiredu JE Tongren V Udhayakumar JK Stiles, Malar J 2007 6 147 17997848 10.1186/1475-2875-6-147
16. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. V Jain HB Armah JE Tongren RM Ned NO Wilson S Crawford PK Joel MP Singh AC Nagpal AP Dash V Udhayakumar N Singh JK Stiles, Malar J 2008 7 83 18489763 10.1186/1475-2875-7-83
17. The cerebral-malaria-associated expression of RANTES, CCR3 and CCR5 in post-mortem tissue samples. BY Sarfo S Singh JW Lillard A Quarshie RK Gyasi H Armah AA Adjei P Jolly JK Stiles, Ann Trop Med Parasitol 2004 98 297 303 10.1179/000349804225003271 15119976
18. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. MJ Blackman IT Ling SC Nicholls AA Holder, Mol Biochem Parasitol 1991 49 29 33 10.1016/0166-6851(91)90127-R 1775158
19. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. MJ Blackman TJ Scott-Finnigan S Shai AA Holder, J Exp Med 1994 180 389 393 7516416 10.1084/jem.180.1.389
20. A 22 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex. WH Stafford B Gunder A Harris HG Heidrich AA Holder MJ Blackman, Mol Biochem Parasitol 1996 80 159 169 10.1016/0166-6851(96)02696-5 8892293
21. The 22 kDa component of the protein complex on the surface of Plasmodium falciparum merozoites is derived from a larger precursor, merozoite surface protein 7. JA Pachebat IT Ling M Grainger C Trucco S Howell D Fernandez-Reyes R Gunaratne AA Holder, Mol Biochem Parasitol 2001 117 83 89 10.1016/S0166-6851(01) 00336-X 11551634
22. The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex. C Trucco D Fernandez-Reyes S Howell WH Stafford TJ Scott-Finnigan M Grainger SA Ogun WR Taylor AA Holder, Mol Biochem Parasitol 2001 112 91 101 10.1016/S0166-6851(00)00350-9 11166390
23. Interactions between merozoite surface proteins 1, 6, and 7 of the malaria parasite Plasmodium falciparum. CW Kauth U Woehlbier M Kern Z Mekonnen R Lutz N Mucke J Langowski H Bujard, J Biol Chem 2006 281 31517 31527 10.1074/jbc.M604641200 16940297
24. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. WA Siddiqui LQ Tam KJ Kramer GS Hui SE Case KM Yamaga SP Chang EB Chan SC Kan, Proc Natl Acad Sci USA 1987 84 3014 3018 3554251 10.1073/pnas.84.9.3014
25. A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections. R Tolle K Fruh O Doumbo O Koita M N'Diaye A Fischer K Dietz H Bujard, Infect Immun 1993 61 40 47 8418064
26. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. MJ Blackman HG Heidrich S Donachie JS McBride AA Holder, J Exp Med 1990 172 379 382 1694225 10.1084/jem.172.1.379
27. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. SP Chang SE Case WL Gosnell A Hashimoto KJ Kramer LQ Tam CQ Hashiro CM Nikaido HL Gibson CT Lee-Ng PJ Barr BT Yokota GS Hut, Infect Immun 1996 64 253 261 8557348
28. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity. F al-Yaman B Genton KJ Kramer SP Chang GS Hui M Baisor MP Alpers, Am J Trop Med Hyg 1996 54 443 448 8644896
29. Human antibodies to the 19 kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. AF Egan P Burghaus P Druilhe AA Holder EM Riley, Parasite Immunol 1999 21 133 139 10.1046/j.1365-3024.1999.00209.x 10205793
30. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. RA O'Donnell TF de Koning-Ward RA Burt M Bockarie JC Reeder AF Cowman BS Crabb, J Exp Med 2001 193 1403 1412 11413195 10.1084/jem.193.12.1403
31. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. OH Branch V Udhayakumar AW Hightower AJ Oloo WA Hawley BL Nahlen PB Bloland DC Kaslow AA Lal, Am J Trop Med Hyg 1998 58 211 219 9502606
32. A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission. EM Riley S Morris-Jones MJ Blackman BM Greenwood AA Holder, Parasite Immunol 1993 15 513 524 10.1111/j.1365-3024.1993. tb00639.x 7877849
33. Enhanced protection against malaria by a chimeric merozoite surface protein vaccine. Q Shi MM Lynch M Romero JM Burns Jr, Infect Immun 2007 75 1349 1358 17158895 10.1128/IAI.01467-06
34. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. YP Shi U Sayed SH Qari JM Roberts V Udhayakumar AJ Oloo WA Hawley DC Kaslow BL Nahlen AA Lal, Infect Immun 1996 64 2716 2723 8698500
35. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. V Udhayakumar D Anyona S Kariuki YP Shi PB Bloland OH Branch W Weiss BL Nahlen DC Kaslow AA Lal, J Immunol 1995 154 6022 6030 7538540
36. Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. K Tanabe M Mackay M Goman JG Scaife, J Mol Biol 1987 195 273 287 10.1016/0022-2836(87)90649-8 3079521
37. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). LH Miller T Roberts M Shahabuddin TF McCutchan, Mol Biochem Parasitol 1993 59 1 14 10.1016/0166-6851(93)90002-F 8515771
38. Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived. K Fruh O Doumbo HM Muller O Koita J McBride A Crisanti Y Toure H Bujard, Infect Immun 1991 59 1319 1324 2004813
39. Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum. U Woehlbier C Epp CW Kauth R Lutz CA Long B Coulibaly B Kouyate M Arevalo-Herrera S Herrera H Bujard, Infect Immun 2006 74 1313 1322 16428781 10.1128/IAI.74.2.1313-1322.2006
40. Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. DR Cavanagh C Dobano IM Elhassan K Marsh A Elhassan L Hviid EA Khalil TG Theander DE Arnot JS McBride, Infect Immun 2001 69 1207 1211 11160024 10.1128/IAI.69.2.1207-1211.2001
41. Differential antibody responses to Plasmodium falciparum glycosylphosphatidylinositol anchors in patients with cerebral and mild malaria. R Perraut B Diatta L Marrama O Garraud R Jambou S Longacre G Krishnegowda A Dieye DC Gowda, Microbes Infect 2005 7 682 687 15848275
42. Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village. R Perraut L Marrama B Diouf C Sokhna A Tall P Nabeth JF Trape S Longacre O Mercereau-Puijalon, J Infect Dis 2005 191 264 271 10.1086/426398 15609237
43. Humoral response to defined Plasmodium falciparum antigens in cerebral and uncomplicated malaria and their relationship to parasite genotype. F Al-Yaman B Genton JC Reeder D Mokela RF Anders MP Alpers, Am J Trop Med Hyg 1997 56 430 435 9158053
44. Cerebral malaria is associated with IgG2 and IgG4 antibody responses to recombinant Plasmodium falciparum RIFIN antigen. N Schreiber N Brattig J Evans A Tsiri RD Horstmann J May MQ Klinkert, Microbes Infect 2006 8 1269 1276 10.1016/j.micinf.2005.12.007 16679041
45. Serum antibody levels to glycosylphosphatidylinositols in specimens derived from matched Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls. Y Cissoko M Daou KE Lyke A Dicko I Diarra A Kone A Guindo K Traore G Krishnegowda DA Diallo OK Doumbo CV Plowe DC Gowda MB Sztein, Am J Trop Med Hyg 2006 75 199 204 16896119
46. Re-emergence of malaria in India. VP Sharma, Indian J Med Res 1996 103 26 45 8926025
47. Evaluation of a rapid diagnostic test, 'Determine malaria pf', in epidemic-prone, forest villages of central India (Madhya Pradesh). N Singh N Valecha, Ann Trop Med Parasitol 2000 94 421 427 10.1080/00034980057446 10983554
48. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000 94 Suppl 1 S1 90 11103309
49. Expression and purification of Plasmodium falciparum MSP-1(42): A malaria vaccine candidate. C Epp CW Kauth H Bujard R Lutz, J Chromatogr B Analyt Technol Biomed Life Sci 2003 786 61 72 10.1016/S1570-0232(02)00722-5 12651002
50. The merozoite surface protein 1 complex of human malaria parasite Plasmodium falciparum: interactions and arrangements of subunits. CW Kauth C Epp H Bujard R Lutz, J Biol Chem 2003 278 22257 22264 10.1074/jbc.M302299200 12654909
51. Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria. JE Tongren CJ Drakeley SL McDonald HG Reyburn A Manjurano WM Nkya MM Lemnge CD Gowda JE Todd PH Corran EM Riley, Infect Immun 2006 74 257 264 16368979 10.1128/IAI.74.1.257-264.2006
52. Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea. F al-Yaman B Genton RF Anders M Falk T Triglia D Lewis J Hii HP Beck MP Alpers, Am J Trop Med Hyg 1994 51 593 602 7985752
53. Humoral response to Plasmodium falciparum ring-infected erythrocyte surface antigen in a highly endemic area of Papua New Guinea. F al-Yaman B Genton M Falk RF Anders D Lewis J Hii HP Beck MP Alpers, Am J Trop Med Hyg 1995 52 66 71 7856827
54. A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. DR Cavanagh IM Elhassan C Roper VJ Robinson H Giha AA Holder L Hviid TG Theander DE Arnot JS McBride, J Immunol 1998 161 347 359 9647243
55. Plasmodium falciparum merozoite surface protein 6 is a dimorphic antigen. JA Pearce T Triglia AN Hodder DC Jackson AF Cowman RF Anders, Infect Immun 2004 72 2321 2328 15039357 10.1128/IAI.72.4.2321-2328.2004
56. Plasmodium falciparum merozoite surface protein 6 (MSP-6) derived peptides bind erythrocytes and partially inhibit parasite invasion. R Lopez J Valbuena LE Rodriguez M Ocampo R Vera H Curtidor A Puentes J Garcia LE Ramirez ME Patarroyo, Peptides 2006 27 1685 1692 10.1016/j.peptides.2006.02.001 16713025
57. Plasmodium falciparum merozoite surface protein 6 displays multiple targets for naturally occurring antibodies that mediate monocyte-dependent parasite killing. S Singh S Soe C Roussilhon G Corradin P Druilhe, Infect Immun 2005 73 1235 1238 15664972 10.1128/IAI.73.2.1235-1238.2005
58. Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates. A Mamillapalli S Sunil SS Diwan SK Sharma PK Tyagi T Adak H Joshi P Malhotra, Malar J 2007 6 95 17659072 10.1186/1475-2875-6-95
59. Genetic structure of Plasmodium falciparum field isolates in eastern and north-eastern India. H Joshi N Valecha A Verma A Kaul PK Mallick S Shalini SK Prajapati SK Sharma V Dev S Biswas N Nanda MS Malhotra SK Subbarao AP Dash, Malar J 2007 6 60 17517129 10.1186/1475-2875-6-60
60. Genetic diversity in the merozoite surface protein 1 gene of Plasmodium falciparum in different malaria-endemic localities. DK Raj BR Das AP Dash PC Supakar, Am J Trop Med Hyg 2004 71 285 289 15381807
61. Anti-merozoite surface protein-1 19-kDa IgG in mother-infant pairs naturally exposed to Plasmodium falciparum: subclass analysis with age, exposure to asexual parasitemia, and protection against malaria. V. The Asembo Bay Cohort Project. OH Branch AJ Oloo BL Nahlen D Kaslow AA Lal, J Infect Dis 2000 181 1746 1752 10.1086/315424 10823777
62. Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian amazon region. LA Da Silveira ML Dorta EA Kimura AM Katzin F Kawamoto K Tanabe MU Ferreira, Infect Immun 1999 67 5906 5916 10531247
63. Naturally acquired antibody responses to the components of the Plasmodium falciparum merozoite surface protein 1 complex. L Wang L Crouch TL Richie DH Nhan RL Coppel, Parasite Immunol 2003 25 403 412 10.1111/j.1365-3024.2003.00647. x 14651587
64. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. AF Egan JA Chappel PA Burghaus JS Morris JS McBride AA Holder DC Kaslow EM Riley, Infect Immun 1995 63 456 466 7822010